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Abstract: Multidrug resistance was an obstacle in cancer chemotherapy because the cells decreased 
their intracellular drug accumulation by energy-dependent compounds efflux pumps such as P-
glycoprotein (P-gp). This study observed some iodinated radiographic contrast media, diatrizoate, 
iopromide and iotrolan affected the cellular energetic state and the kinetics of P-gp in drug-sensitive 
K562 and drug resistant K562/adr  cell lines using spectrophotometer and spectrofluorometer. By 
colorimetric MTT assay, it was found that contrast media (0-3500 µM) had no effect on both K562 and 
K562/adr cell viabilities, but in co-treatment with daunorubicin (DNR), diatrizoate decreased cell 
viability in K562/adr cells by decreasing ICso of DNR from 610.7 ±74.5 nM to 360±108.9 nM. The 
change in cellular energetic state was studied using rhodamine B as a probe to estimate mitochondrial 
membrane potential (∆Ψm). The results showed that 3500 µM diatrizoate decreased ∆Ψm from 
162.2±0.3 mV to 86.9±9.9 mV in K562/adr cells. The kinetics of P-gp-mediated efflux of DNR could 
be reduced by diatrizoate from 0 (no inhibition) to 0.65±0.11. This inhibition could be partially 
prevented in co-incubation with 20 nM concanamycin A or 10 µM cytochalasin B. Among the three 
molecules, diatrizoate showed the best efficiency. It could be proposed for further studies that 
diatrizoate could be used as MDR identification or MDR imaging and also acted as MDR sensitizing 
agent in cancer treatments. 
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INTRODUCTION 
 
  Iodinated radiographic contrast media are used in 
clinical practice as diagnostic pharmaceuticals to 
indicate the site and size of pathology, including cancer 
staging. The most widely used contrast media are water 
soluble, fully substituted, triiodinated benzoic acid 
derivatives. They are commonly classified according to 
two characteristics, ionic versus non ionic and 
monomer versus dimer
[1]. Tolerability of modern 
contrast media is very high that the huge amount (up to 
100-200 g in total number) of drug can be injected as a 
bolus with a side effect coincidence of less than 5%
[2]. 
However, the administered contrast media into blood 
vessels (about 1-2 mI kg
−1, ~300 mg of iodine per 
milliliter, 600-1500 mOsm) generated a concentration-
dependent effect on neutrophils. In particular, ionic 
contrast media dramatically decreased in the 
mitochondrial membrane potential (∆Ψm) of 
neutrophils, affecting the membrane permeability that 
would allow the anion portion to actually penetrate into 
the cells
[3]. The same effects of contrast media on 
mitochondrial activity and on reduction of ATP level in 
LLC-PK1 and HRPTE cells were reported
[4]. Moreover, 
some radiographic contrast media such as iohexol, a 
monomer-non ionic contrast medium affect MRP2- and 
P-gp-mediated transport of Fluorescein-Methotrexate 
(FL-MTX) and a fluorescent cyclosporine derivative 
(NBD-CSA) in intact killifish renal proximal tubules
[5]. 
However, the direct effects of contrast media on the 
MDR transporters such as P-glycoprotein and MRP1 
did not study yet. Such activities of these hyperdensity Am. J. Applied Sci., 6 (3): 484-491, 2009 
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molecules could be clearly demonstrated by using 
multidrug-resistant cancer cell lines. 
  In this study, the erythromyelogenous leukemic 
K562 and its P-glycoprotein overexpression K562/adr 
cells were used for investigating the effects of contrast 
media on the function of P-glycoprotein and the 
mitochondrial function. All the contrast media used 
affected the cellular energetic state only in MDR cells 
by decreasing in ∆Ψm and in the P-glycoprotein 
function leading to the restoration of intracellular 
daunorubicin concentration consequently the 
cyotoxicity was increased in the drug-resistant cells. 
The results provide a new possible application of 
contrast media other than usual utilization. The 
combination with appropriate mitochondrial probe that 
accumulated in the cells depending on ∆Ψm, the 
contrast media could be used as a mitochondrial 
energetic state modulator that was specific to MDR 
cells.  
 
MATERIALS AND METHODS 
 
Drugs and Chemicals: Adriamycin (Dox) and 
daunorubicin (DNR) were kindly provided by Professor 
Arlette Garnier-Suillerot, Laboratoire de Chimie 
Physique Biomoleculaire et Cellulaire, UFR Sante 
Medicine et Biologie Humaine, Bobigny, Université de 
Paris Nord, France. Iodinated radiographic contrast 
media, diatrizoate (Angiografin, Schering AG, 
Germany), iopromide (Ultravist, Schering AG, 
Germany) and iotrolan (Isovist, Schering AG, 
Germany) were kindly provided by Department of 
Radiology, Sappasitthiprasong Hospital, 
Ubonratchatani, Thailand. Rhodamine B and 
tetrazolium salt (3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyl-2H-tetrazolium bromide (MTT) were from 
Amresco. Concanamycin A and cytochalasin B were 
from Sigma Chemical Co.  
  Deionized double distilled water was used 
throughout the experiments for solutions and buffers. 
Stock solutions of adriamycin (Dox) and daunorubicin 
(DNR) were prepared in water just before use and their 
concentrations were determined by UV-Visible 
Spectrophotometer, using a molar extinction coefficient 
of 11500 M
−1 cm
−1 at 480 nm
[6]. The dilutions of 
contrast media (diatrizoate, iopromide and iotrolan) 
were freshly prepared before used in water from known 
concentrations of these compounds in the commercially 
available solutions, stated in the manufacturer's 
information. Stock solution of MTT was prepared by 
dissolving 5 mg MTT mL
−1 (12 mM) in HEPES-Na
+ 
buffer and filtered through a 0.22 µm filter then stored 
at 4°C. A stock solution of cytochalasin B was prepared 
in DMSO (dimethyl sulphoxide) and stored at less than 
(-20°C). The absorption spectra were recorded on a 
Hewlett Packard G1103A spectrophotometer and the 
fluorescence spectra were recorded on a Perkin Elmer 
LS 50 B spectrofluorometer. 
 
Cell lines and cell culture conditions: The 
adriamycin-sensitive erythromylogenous leukemic cell 
line, K562 and its P-glycoprotein-overexpressing 
K562/adr cells
[6,7] were kindly provided by Professor 
Arlette Garnier-Suillerot, Laboratoire de Chimie 
Physique Biomoleculaire et Cellulaire, UFR Sante 
Medicine et Biologie Humaine, Bobigny, Université de 
Paris Nord, France. These cells were routinely cultured 
in RPMI 1640 medium supplemented with 1% 
penicillin-streptomycin (Sigma Chemical Co.) and 10% 
fetal bovine serum (Gibco Biocult Ltd.) at 37°C in a 
humidified incubator at 95% air and 5% CO2. The 
resistant K562/adr cells were cultured with 100 nM 
doxorubicin two weeks before the experiments. The 
cultures were initiated at a density of 1×10
5 cells mL
−1, 
grew exponentially to about 8 -10×10
5 cells mL
−1 in 3 
days. For the assays, the cultures were initiated at 5×10
5 
cells mL
−1 to have cells in the exponential growth phase 
and were used 24 h later after reaching a density of 
approximately 8-10×10
5 cells mL
−1. Cell viability was 
assessed by Trypan blue exclusion. The number of cells 
was determined by a haemocytometer. 
 
Cytotoxicity assay: The viability of cells was 
determined using colorimetric MTT- reduction assay 
with some modification
[7,8]. Briefly, cells (5×10
4 cells 
mL
−1) were incubated in RPMI-1640 medium 
supplemented with 10% fetal bovine serum in the 
presence of various concentrations of contrast media 
(diatrizoate, iopromide, or iotrolan) at 37°C in a 
humidified incubator with 95% air and 5% CO2. After 
72 h, 2 mM final concentration MTT was added to the 
cell suspension and then further incubated for 4 h. The 
concentration of daunorubicin and pirarubicin required 
to inhibit cell proliferation by 50% when measured at 
72 h (IC50) was determined by plotting the percentage 
of cell growth inhibition versus drug concentration. The 
Resistance Factor (RF) was defined as the IC50 of 
resistant cells divided by the IC50 of sensitive cells and 
was equal to 40.  
 
Co-treatment of daunorubicin and contrast media: 
Cells (5×10
4 cells mL
−1) were incubated in RPMI-1640 
medium supplemented with 10% fetal bovine serum in 
the presence of various concentrations of daunorubicin 
and a fixed concentration of 0.5, 2.0 and 3.5 mM 
contrast media (diatrizoate, iopromide, or iotrolan). The Am. J. Applied Sci., 6 (3): 484-491, 2009 
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experiments were performed and calculated using 
colorimetric MTT- reduction assay as described 
previously. The efficacy of contrast media (δ) in 
increasing the efficacy of daunorubicin was obtained by 
the following equation:  
 
δ = [IC50(R)-IC50(RCM)]/[IC50(R)-IC50(S)] 
 
where IC50(R) was the concentration of daunorubicin 
that inhibited 50% of MDR cell growth, IC50(RCM) was 
the concentration of drug that inhibited 50% of MDR 
cell growth in the presence of contrast media and IC50(S) 
is the concentration of drug that inhibited 50% of drug-
sensitive cell growth
[9].  
 The  δ was equal to 0 when the MDR cells were 
treated with daunorubicin alone and δ was equal to 1 
when the contrast media reverse 100% of the MDR 
phenotype resulting in the same IC50(RCM) as that of drug 
sensitive cell line. 
 
The effect of contrast media on mitochondrial 
membrane potential (∆Ψm):  The mitochondrial 
membrane potential (∆Ψm) was measured using a non-
invasive functional study
[10], which can be used to 
determine and to monitor a spontaneous change in 
mitochondrial functions in drug-sensitive and drug-
resistant cells. Cells (2×10
6 cells) were incubated with 
various concentrations of contrast media, diatrizoate, 
iopromide and iotrolan in 2 mL of HEPES- Na
+ buffer 
with 40 nM rhodamine B in 1 cm quartz cuvette and 
vigorously stirred at 37°C. The rhodamine B 
fluorescence intensity (F) at 582 nm (excited at 553 
nm) was monitored as a function of time. The addition 
of 200 µM MTT were performed within 10 min of 
incubation, yielding a progressive decrease in 
rhodamine B fluorescence intensity. The estimation of 
∆Ψm was done using Nernst equation: C°m/C°i 
=10
(∆ΨmF/2.303RT) and ∆Ψm = -61.51logVi-258.46, where 
∆Ψm is the mitochondrial membrane potential in mV, 
RT/F is 26mV at 37°C, C°i is 40 nM and Vi  is in 
nM.s
−1. 
 
Modulation of kinetics of the p-glycoprotein- 
mediated efflux of daunorubicin by contrast media: 
Cells (2×10
6 cells) were incubated in 2 mL HEPES-K
+ 
buffer in the absence of glucose under continuous 
stirring at 37 °C in 1-cm quartz cuvette. The 
extracellular pH (pHe) of 7.25 was chosen all the 
experiments to be equal to the pH of cytoplasm since 
the cytosolic pH in K562/adr cells was shown to be 
within the range of 7.2-7.3
[11]. Initially, the cells were 
depleted energy by adding 10 mM NaN3, an inhibitor of 
cytochrome oxidase in mitochondrial electron transport 
chain for 30 min, leading to depletion of ATP in these 
cells about 90%. The cells remained viable throughout 
the experiment as checked by trypan blue exclusion. 
Daunorubicin (DNR) was added to cell suspension at 
concentration of 1 µM. The fluorescence intensity of 
DNR at 590 nm (excited at 480 nm) was 
spectrofluorometrically followed as a function of time. 
A decrease in fluorescence intensity was observed 
during incubation with cells, due to quenching of 
fluorescence after the intercalation of DNR between the 
base pairs of DNA. At the first steady state, the 
intracellular free drug concentration C'i was equal to the 
free drug concentration in the extracellular medium (Ce) 
when pHi equals pHe. Then 5mM glucose was added at 
t = tglu, after the sequential addition of various 
concentrations of contrast media resulting in an 
increasing the fluorescence intensity at 590 nm. The 
slope of the tangent to the curve was (dF/dt) tglu and the 
kinetics of release of DNR (Va) was: Va = (dF/dt) tglu . 
(CT/F0) in µM.s
−1. The mean rate constant (ka) of P-
glycoprotein- mediated can be written as: ka = Va/n( (CT 
- C'n) in s
−1. The ability of contrast media to inhibit the 
P-glycoprotein active efflux of a drug can be 
determined using the ratio of k
i
a / k
0
a where k
i
a and k
0
a 
were stand for the P-glycoprotein -mediated efflux 
coefficient in the presence and in the absence of 
contrast media, respectively. When k
i
a / k
0
a is equal to 1 
that means there is no inhibition of active efflux and to 
0 means the P-glycoprotein active efflux is completely 
blocked. 
 
RESULTS AND DISCUSSION 
 
Enhancement of daunorubicin cytotoxicity: All 
contrast media studied at the concentrations up to 3.5 
mM did not inhibit the cell growth of both K562 and 
K562/adr cell line. Contrary to daunorubicin, an 
anticancer drug belongs to anthracycline family, IC50 
value is 17.5±0.1 nM for K562 and 610±74 nM for 
K562/adr cells. It was clear that the co-treatment using 
daunorubicin and various concentration of diatrizoate, 
iopromide or iotrolan (0.5, 2.0 and 3.5 mM) did not 
affect the IC50 of daunorubicin in drug-sensitive K562 
cells. However, these compounds increased the efficacy 
of daunorubicin when similar conditions of series of 
experiments were performed with drug-resistant 
K562/adr cells (Fig. 1). The capabilities of 0.5, 2.0 and 
3.5 mM diatrizoate in increasing the efficacy of DNR 
(δ) were 0.11, 0.17 and 0.45, respectively.  Am. J. Applied Sci., 6 (3): 484-491, 2009 
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Fig.  1:  Concentration of daunorubicin required to 
inhibit cell growth by 50% (IC50) in the presence 
of contrast media; iotrolan (), iopromide ( ), 
and diatrizoate (c) in (a) K562 cell line and (b) 
K562/adr cell line. Cells (5×10
4 cells mL
−1) 
were incubated with various concentrations of 
daunorubicin and a fixed concentration of 
contrast media (0.5, 2.0 or 3.5 mM) in 24-well 
plates at 37°C for 72 h. The cells were harvested 
after 4-hour of 2 mM MTT incubation. The 
formazan was spectrophotometically measured 
at 560 nm. Each value is the mean±SD of three 
independent experiments 
 
Inhibition of the P-glycoprotein- mediated efflux of 
daunorubicin by contrast media: The effects of 
contrast media on the P-glycoprotein function could be 
determined by monitoring the efficiency of protein 
mediated efflux of daunorubicin in the absence and 
presence of contrast media. The ka of daunorubicin in 
the absence of contrast media was equal to 0.67±0.06 
pL. cell
−1 sec
−1. The efficacy of contrast media that can 
inhibit the function of P-glycoprotein in the presence of 
0.5, 2.0 and 3.5 mM of diatrizoate, iopromide or 
iotrolan were indicated in Fig. 2. 
  In fact, the contrast media are hyperdensity 
molecules that affected the cellular morphology, which 
could be easily observed by light microscope. Cell 
shrinkage was immediately occurred after contrast 
media addition to the cells and then they returned to 
normal morphology in a short time. This phenomenon 
could affect various cellular physiologies of cells such 
as acidification of the pHi then followed by a correction 
of volume then pHi, leading to modifications in protein 
synthesis
[12] and particularly, the change in membrane 
conformation could influence the function of P-gp. 
  In order to verify the direct interaction of contrast 
media on P-gp, two series of experiments were 
performed.    The   first    set   of   experiments,   the  P- 
 
 
Fig.  2:  Ratio of the mean P-gp-mediated efflux of 
daunorubicin in the presence to the absence of 
iotrolan (), iopromide ( ) or diatrizoate (c) 
in K562/adr cell line. The experiments were 
performed by following the fluorescence 
intensity of 1 µM DNR (λex = 480 nm, λem= 590 
nm) in 2×10
6 cells in 2 mL HEPES K
+buffer, pH 
7.25 at 37°C, which were depleted energy by 
adding 10 mM NaN3 30 min before 
daunorubicin addition. After the first steady 
state, 5 mM glucose was added before addition 
of contrast media then the active efflux 
coefficient of P-gp (ka) was measured. Each 
value represents the mean±SD of three 
independent experiments. Inset The overall 
cellular accumulation of daunorubicin in 
K562/adr cells in the absence or presence of 
iotrolan (), iopromide ( ) and diatrizoate (c) 
at various concentrations 
 
glycoprotein-mediated efflux of daunorubicin was 
measured in the MDR cells after treated using 10 µM 
cytochalacin B for 24h in the presence or absence of 
contrast media. Furthermore, using cytochalasin B, a 
chemical that inhibits polymerization of F-actin, that is 
one of important mechanisms of endocytosis or fixing 
the membrane movements
[13,14]. The second set of 
experiments, the P-glycoprotein-mediated efflux of 
daunorubicin was measured in the MDR cells after 
treated using 20 nM concanamycin A for 10 minutes. 
Concanamycin A was used to inhibit the action of 
vacular H
+-translocating ATPases that presence at the 
lysosomal membrane but did not inhibit the P-
glycoprotein mediated-efflux of drugs
[15,16]. Indeed, 
these conditions of experiments would protect the 
contrast media uptake by MDR cells. Figure 3a clearly 
showed that there was an increase in the P-
glycoprotein-mediated efflux of daunorubicin in the 
presence of 3.5 mM diazoate. Similar results were 
obtained  when  the  series  of  experiments with similar  Am. J. Applied Sci., 6 (3): 484-491, 2009 
 
  488
 
 
Fig. 3: Effects of 20 nM concanamycin A, or 10 µM 
cytochalasin B on P-gp-mediated efflux in 
K562/adr cells, which was modulated by 3.5 
mM contrast media, (a) the kinetic studies in the 
presence of diatrizoate without and with 20 nM 
concanamycin A or 10 µM cytochalasin B, and 
(b) ka
i/ka
0 in the presence of CM without ( ) 
and with 20 nM concanamycin A ( ) or 10 µM 
cytochalasin B ( ). Each value is the mean±SD 
of three independent experiments 
 
conditions were performed using iopromide or iotrolan. 
Figure 3b demonstrates that an increase in the ratio of 
ka
i/ka
0 of the series of experiments with treatment with 
non-treatment (p<0.05).  
 
The effect of contrast media on mitochondrial 
membrane potential (∆Ψm):  The uptake of contrast 
media by cells would be caused an additional 
consumption of ATP which can be resulted in a 
depletion of cellular ATP contents which is insufficient 
to assure the P-glycoprotein function. These impaired 
cellular energetic state can directly studied by 
measuring the mitochondrial membrane potential 
(∆Ψm). The ∆Ψm values determined for K562 and drug- 
resistant K562/adr cells were 166.2±5.7 mV and 
162.2±0.3  mV,  respectively.  It  was found that among  
 
 
Fig.  4:  Variation of the absolute values of the 
mitochondrial membrane potential (∆Ψm) in 
intact cells (a) K562 and (b) K562/adr in the 
presence of iotrolan (), iopromide ( ) and 
diatrizoate (c) at concentration of 0, 350 and 
3500 µM. Each value is the mean±SD of three 
independent experiments 
 
the contrast media used, diatrizoate (0.35, 3.5 mM) that 
apparently decreased ∆Ψm in K562/adr cells, whereas 
iopromide could do with less efficiency and iotrolan 
was the least to do. Otherwise, in K562 cell line, there 
were no differences between treated cells and control 
(Fig. 4). 
  The iodinated radiographic contrast media used in 
this study included diatrizoate (an ionic monomer), 
iopromide (a non-ionic monomer) and iotrolan (a non-
ionic dimer). These molecules are intravenously 
administered in patients undergo Intravenous 
Pyelography (IVP) or computed tomography, which are 
the standard imaging modalities used to radiologically 
stage some cancers
[17]. The cytotoxicity of contrast 
media was determined by the cell growth inhibition 
dose (IC50). At the concentrations used in the 
experiments, they did not affect the cell proliferation of 
K562 and its corresponding MDR cell line. These 
concentrations were comparable to and did not over-
exceed the concentration administered in clinical uses 
(the average clinical concentration in blood circulation 
after IV. injection is about 2.5 mgI mL
−1, dose 
recommended by Schering AG, 1 mL of 300 mgI mL
−1 
of contrast media per 1 kg body weight, whereas 
concentrations in this study are 0.15 - 2.66 mgI mL
−1.). 
Although the contrast media themselves at the 
concentrations used in this study were not toxic to the 
cells, they (especially diatrizoate, an ionic monomer) 
were found, in co-treatment with daunorubicin, to 
enhance the efficiency of this anti-cancer drug to inhibit 
cell proliferation in the resistant K562/adr cell line. It Am. J. Applied Sci., 6 (3): 484-491, 2009 
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means that contrast media affected the function of P-
glycoprotein, which was an active drug efflux 
transporter in this MDR cell line, therefore increasing 
the cytotoxicity of daunorubicin. 
  The study on the change of cellular energetic state 
was done by following the change in mitochondrial 
membrane potential (∆Ψm) of drug-sensitive and drug-
resistant cells using rhodamine B. The mitochondrial 
membrane potential is essential for the production of 
ATP via oxidative phosphorylation. In situ, it is a 
sensitive indicator for the energetic state of the 
mitochondria and cells. It should be noted that even a 
slight decrease in the ∆Ψm could affect the cellular 
energetic state
[9,10]. Indeed, the three molecules of 
contrast media were able to decrease ∆Ψm in drug-
resistant K562/adr cells, but not in drug sensitive K562 
cells, with different degree. The aptitude to induce a 
decrease in ∆Ψm could be obviously seen in diatrizoate 
at high concentration, thus this reduced intracellular 
ATP. This was reasonably supported by the findings in 
literatures
[18,19] that intracellular ATP could be reduced 
following the exposure of diatrizoate in animal kidney 
cells, which were also expressed some drug transporters 
such as MRP2 and P-gp
[5]. However, the co-incubation 
with contrast media did not affect the cytotoxicity of 
daunorubicin in drug-sensitive K562 cells, in 
comparison with drug-resistant K562/adr cells, which 
need more ATP to assure their ATPase activity of 
protein membrane transporter, i.e. P-glycoprotein. The 
function of P-glycoprotein was lessened resulting in an 
increase in intracellular cytotoxic agent, leading to 
MDR cell death
[20].  
  In vitro and in vivo MDR cell imaging is of 
uppermost importance for successful cancer 
chemotherapy. In this work, it was demonstrated that 
diatrizoate could probably be used as modulator of ∆Ψm 
in combination with some mitochondrial probes such 
as, for in vitro studies, DiOC6, JC-1
[21,22] and rhodamine 
derivatives
[10] and for in vivo studies, 
99mTc-
sestamibi
[23]. With an appropriate choice of probe, this 
modulation could be employed to distinguish the MDR 
cells or even to make the image of MDR cells, because 
only the MDR cells, herein K562/adr, would be 
affected by diatrizoate. This is the case, for example, of 
99mTc- sestamibi, the γ-emitting probe that was 
administered in patients for localizing and imaging 
cancer in diagnostic nuclear medicine. Upon addition of 
diatrizoate, the chemo-resistant cancer cells would be 
recognized in low profile compared to the responsive 
cells. 
  The efficacies of diatrizoate, iopromide and 
iotrolan to inhibit the P-glycoprotein-mediated 
daunorubicin efflux in MDR cells were as well 
observed. This work had investigated the aptitude of 
these contrast media to inhibit the P-glycoprotein-
mediated efflux by following the uptake of 
daunorubicin by K562/adr cells, demonstrated with the 
ratio k
i
a/ka
0 as a function of contrast medium 
concentration added. Among the three molecules, 
diatrizoate had the highest capacity to inhibit the P-
glycoprotein-mediated efflux. Furthermore, this was 
confirmed by treating experimental MDR cells with 
concanamycin A and cytochalasin B. Since the active 
binding sites of protein membrane transporter, P-
glycoprotein, were located intracellularly, any 
molecules or compounds that regulated P-glycoprotein 
had to do from inside of the cell. Considerately, the 
physicochemical properties of contrast media 
determined (unpublished data) and referred to in 
literatures
[24,25], diatriziate, iopromide and iotrolan 
could uptake into cells by endocytosis where molecules 
were engulfed and retained in vacuoles, which 
represented a part of lysosomal compartment
[24]. 
Concanamycin A was used to inhibit the action of 
vacuolar H
+-translocating ATPases that presented on 
membrane of lysosome, but did not inhibit the P-
glycoprotein-mediated efflux of drug
[15]. In addition, 
cytochalasin B was used to inhibit a wide variety of 
cellular movements that is one of important 
mechanisms of endocytosis by interacting with 
microfilaments in the cells
[13]. These two compounds 
prevented contrast media to get inside the cell, leading 
to higher capability of P-glycoprotein-mediated efflux, 
when compared with the conditions that contrast media 
were added alone. The efficacy of contrast media, 
especially diatrizoate, to impair the function of P-gp 
seemed very apparent but the mechanism(s) of this 
modulation still was not clear whether they were 
substrates of P-gp or they affected the energy 
consumption of P-gp as mentioned above. 
  In general, most studies have focused on the effects 
of contrast media on kidney cells since they were 
excreted by nephron units after intravenous 
administration into patients. This is the first study to 
show that they also affected cellular energetic state and 
the function of P-glycoprotein in MDR cancer cells. 
 
CONCLUSION 
 
  The iodinated radiographic contrast media in 
diagnostic radiography, diatrizoate (an ionic monomer), 
iopromide (a nonionic monomer) and iotrolan (a non 
ionic dimer) were relatively low cytotoxicity at the 
concentrations used that was comparable to the dosage 
administered in clinics. However, in the co-treatment Am. J. Applied Sci., 6 (3): 484-491, 2009 
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with daunorubicin, an anticancer drug that was a 
substrate of P-glycoprotein, diatrizoate could enhance 
the efficacy of this anticancer drug in K562/adr cells. 
All the contrast media used affected the cellular 
energetic state only in MDR cells by decreasing ∆Ψm 
and inhibit P-glycoprotein function, leading to the 
restoration of intracellular drug concentration, 
consequently, the cytotoxicity was increased in the 
drug-resistant cells. The results provide a new possible 
application of contrast media other than usual 
utilization. In combination with appropriate 
mitochondrial probe that accumulated in the cells 
depending on ∆Ψm, the contrast media could be used as 
a mitochondrial energetic state modulator that was 
specific to MDR cells (K562/adr cells). This study had 
led to some points of view that diatrizoate might be 
raised for further study as MDR identification in MDR 
imaging in vitro or in vivo with the help of some probes 
that their main target were in mitochondria and, 
eventually, a MDR chemo-sensitizing agent in cancer 
treatment. 
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